Skip to content
★ Sign in to follow
AL

Anila Lingamneni

Chief Technology Officer
Total declarations
25
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (9 ops.)
€867k

Latest filing published 15 Jul 2024 for HAEMONETICS CORP, €6,539.

Filing timeline

BuySale
Anila Lingamneni

Insider track record

Disclosed buys
0
Disclosed sells
9
Signal history

Anila Lingamneni: trading record in brief

Anila Lingamneni is a declared insider of Haemonetics Corp (senior executive), with filings sourced from SEC (Form 4). Between 15 April 2020 and 12 July 2024, the trades on record add up to 25 filings.

Sales make up the whole of the open-market record (9 sales, €867k). The rest of the record consists of 16 share grants. 2024 to date brings no purchases and 3 sales.

The newest entry dates from 15 July 2024: an open-market sale of €6,539, in Haemonetics Corp. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Anila Lingamneni

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations25 total
  • ▼
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    7,110 USD11SEC
    79 shares@ US$90.000.4% of flowCommon StockSEC:0001127602-24-020383:1
  • ▼
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    192,240 USD13SEC
    2,136 shares@ US$90.0017.1% of flowCommon StockSEC:0001127602-24-020383:0
  • ◆
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    505,359 USD14SEC
    5,279 shares@ US$95.7329.4% of flowCommon StockSEC:0001127602-24-016816:1
  • ◆
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    0SEC
    14,140 shares0Common StockSEC:0001127602-24-016816:0
  • ◆
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    0SEC
    3,394 sharesCommon StockSEC:0001127602-24-016171:1
  • ◆
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    33,410 USD11SEC
    349 shares@ US$95.733.0% of flowCommon StockSEC:0001127602-24-016171:0
  • ◆
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    30,146 USD11SEC
    318 shares@ US$94.801.8% of flowCommon StockSEC:0001127602-24-015834:1
  • ◆
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    32,517 USD11SEC
    337 shares@ US$96.492.9% of flowCommon StockSEC:0001127602-24-015834:0
  • ▼
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    218,975 USD13SEC
    2,305 shares@ US$95.0019.6% of flowCommon StockSEC:0001127602-24-014594:0
  • ◆
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    15,618 USD11SEC
    184 shares@ US$84.881.4% of flowCommon StockSEC:0001127602-24-013101:0
  • ▼
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    207,450 USD28SEC
    2,305 shares@ US$90.0018.6% of flowCommon StockSEC:0001127602-23-024071:0
  • ▼
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    191,992 USD13SEC
    2,304 shares@ US$83.3317.3% of flowCommon StockSEC:0001127602-23-017355:0
  • ◆
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    115,426 USD12SEC
    1,385 shares@ US$83.3410.3% of flowCommon StockSEC:0001127602-23-016314:0
  • ◆
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    28,369 USD11SEC
    318 shares@ US$89.211.6% of flowCommon StockSEC:0001127602-23-015939:1
  • ◆
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    0SEC
    3,364 sharesCommon StockSEC:0001127602-23-015939:0
  • ◆
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    14,921 USD11SEC
    176 shares@ US$84.781.3% of flowCommon StockSEC:0001127602-23-013161:0
  • ▼
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    81,794 USD30SEC
    1,384 shares@ US$59.107.5% of flowCommon StockSEC:0001127602-22-015366:0
  • ◆
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    0SEC
    4,340 sharesCommon StockSEC:0001127602-22-014984:0
  • ▼
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    10,688 USD11SEC
    189 shares@ US$56.551.0% of flowCommon StockSEC:0001127602-22-012143:0
  • ▼
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    5,077 USD29SEC
    92 shares@ US$55.190.4% of flowCommon StockSEC:0001127602-21-017682:2
  • ◆
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    0SEC
    7,070 sharesCommon StockSEC:0001127602-21-017682:1
  • ◆
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    0SEC
    3,535 sharesCommon StockSEC:0001127602-21-017682:0
  • ▼
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    20,305 USD11SEC
    170 shares@ US$119.441.6% of flowCommon StockSEC:0001127602-21-014117:0
  • ◆
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    0SEC
    1,209 sharesCommon StockSEC:0001127602-20-017268:0
  • ◆
    EVP, Chief Technology OfficerExecutivesHaemonetics Corp
    0SEC
    2,181 sharesCommon StockSEC:0001127602-20-014068:0

25 of 25 declarations